Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares RepurchasedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

GE HealthCare Technologies (GEHC) Other Working Capital Changes (2022 - 2025)

GE HealthCare Technologies' Other Working Capital Changes history spans 4 years, with the latest figure at -$205.0 million for Q4 2025.

  • For the quarter ending Q4 2025, Other Working Capital Changes fell 253.45% year-over-year to -$205.0 million, compared with a TTM value of -$204.0 million through Dec 2025, down 145.78%, and an annual FY2025 reading of -$204.0 million, down 145.78% over the prior year.
  • Other Working Capital Changes for Q4 2025 was -$205.0 million at GE HealthCare Technologies, down from $24.0 million in the prior quarter.
  • The five-year high for Other Working Capital Changes was $291.0 million in Q3 2022, with the low at -$319.0 million in Q2 2022.
  • Average Other Working Capital Changes over 4 years is $125000.0, with a median of $8.0 million recorded in 2023.
  • Biggest YoY gain for Other Working Capital Changes was 423.81% in 2024; the steepest drop was 300.0% in 2024.
  • Tracing GEHC's Other Working Capital Changes over 4 years: stood at $89.0 million in 2022, then decreased by 7.87% to $82.0 million in 2023, then crashed by 170.73% to -$58.0 million in 2024, then plummeted by 253.45% to -$205.0 million in 2025.
  • Per Business Quant, the three most recent readings for GEHC's Other Working Capital Changes are -$205.0 million (Q4 2025), $24.0 million (Q3 2025), and $78.0 million (Q2 2025).